About
A Netherlands-based biotech building the functional genomics platform that precision medicine programmes need.
We are a Netherlands-based biotech building the functional genomics platform that precision medicine programmes need.
Our team brings together expertise in CRISPR gene editing, DNA repair, cancer biology, and rare genetic disease — anchored by geneSlice, our proprietary gene editing platform for functional classification of gene variants at scale.
Connecting variants to treatments
We partner with drug developers and academic groups to functionally classify gene variants at scale. Powered by geneSlice — our proprietary serine integrase-based gene editing platform — our cell-based assays reduce the cost and timeline of identifying which patients will respond to targeted treatments, from pre-clinical target validation through clinical trial patient stratification.
A world where every patient with a genetic disease receives a treatment that works — informed by deep mechanistic understanding of disease biology, and matched to the patient's specific variants.
What we stand for
Patient first
Every project begins and ends with the patients who could benefit.
Challenge the convention
We work in genomic regions and disease areas others can't reach.
Innovate as a team
Cross-disciplinary collaboration is how we move faster, together.
Collaborative & transparent
Clear data, clear caveats, and shared ownership of outcomes.
Active programmes with leading pharmaceutical companies, biotech innovators, and academic partners across oncology and rare disease.
Development partner: TIDE Genetics.